Skip to main content
Erschienen in: Medical Oncology 2/2012

01.06.2012 | Original Paper

MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility

verfasst von: Liang Zhu, Huarong Chen, Donger Zhou, Dan Li, Rui Bai, Shu Zheng, Weiting Ge

Erschienen in: Medical Oncology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Human microRNA-9 (miR-9) has been reported to be involved in the metastasis of several malignancies including brain breast cancer. However, its role in the metastasis of colorectal cancer (CRC) remains to be revealed. Here, we evaluated miR-9 expression in metastatic CRC and investigated its effects on the motility and proliferation of RKO cells. The expressions of miR-9 in 15 primary CRC specimens without distant metastasis (NM group) and 10 primary CRC specimens (M group) with distant metastasis (M group) were determined by quantitative real-time PCR. The alternations in the motility and morphology of RKO cells before and after miR-9 transfection were analyzed by migration assay and F-actin staining. The relationship between miR-9 and α-catenin was identified by Western blotting. Cell growth was examined by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazoliumbromide) assay. Significant difference of miR-9 expression was observed in M group compared to the NM group (P < 0.001). Ectopic expression of miR-9 enhanced the motility of RKO cells as well as changed their morphological appearance, while cell growth remained unchanged. The overexpression of miR-9 could also down-regulate α-catenin expression. These data suggest that miR-9 may potentially participate in the metastatic process of CRC though facilitating cell motility.
Literatur
1.
Zurück zum Zitat Blumgart LH, Fong Y. Surgical options in the treatment of hepatic metastasis from colorectal cancer. Curr Probl Surg. 1995;32(5):333–421.PubMedCrossRef Blumgart LH, Fong Y. Surgical options in the treatment of hepatic metastasis from colorectal cancer. Curr Probl Surg. 1995;32(5):333–421.PubMedCrossRef
2.
Zurück zum Zitat Newland RC, Dent OF, Chapuis PH, Bokey EL. Clinicopathologically diagnosed residual tumor after resection for colorectal cancer. A 20-year prospective study. Cancer. 1993;72(5):1536–42.PubMedCrossRef Newland RC, Dent OF, Chapuis PH, Bokey EL. Clinicopathologically diagnosed residual tumor after resection for colorectal cancer. A 20-year prospective study. Cancer. 1993;72(5):1536–42.PubMedCrossRef
3.
Zurück zum Zitat Zhang H, Li Y, Lai M. The microRNA network and tumor metastasis. Oncogene. 2010;29(7):937–48.PubMedCrossRef Zhang H, Li Y, Lai M. The microRNA network and tumor metastasis. Oncogene. 2010;29(7):937–48.PubMedCrossRef
4.
Zurück zum Zitat Ma L, Young J, Prabhala H, Pan E, Mestdagh P, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol. 2010;12(3):247–56.PubMed Ma L, Young J, Prabhala H, Pan E, Mestdagh P, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol. 2010;12(3):247–56.PubMed
5.
Zurück zum Zitat Nass D, Rosenwald S, Meiri E, Gilad S, Tabibian-Keissar H, et al. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol. 2009;19(3):375–83.PubMedCrossRef Nass D, Rosenwald S, Meiri E, Gilad S, Tabibian-Keissar H, et al. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol. 2009;19(3):375–83.PubMedCrossRef
6.
Zurück zum Zitat Zheng J, Xue H, Wang T, Jiang Y, Liu B, et al. miR-21 downregulates the tumor suppressor P12(CDK2AP1) and stimulates cell proliferation and invasion. J Cell Biochem. 2011;112(3):872–80.PubMedCrossRef Zheng J, Xue H, Wang T, Jiang Y, Liu B, et al. miR-21 downregulates the tumor suppressor P12(CDK2AP1) and stimulates cell proliferation and invasion. J Cell Biochem. 2011;112(3):872–80.PubMedCrossRef
7.
Zurück zum Zitat Roybal JD, Zang Y, Ahn YH, Yang Y, Gibbons DL, et al. miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. Mol Cancer Res. 2011;9(1):25–35.PubMedCrossRef Roybal JD, Zang Y, Ahn YH, Yang Y, Gibbons DL, et al. miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. Mol Cancer Res. 2011;9(1):25–35.PubMedCrossRef
8.
Zurück zum Zitat Fowler A, Thomson D, Giles K, Maleki S, Mreich E, et al. miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion. Eur J Cancer. 2011;47(6):953–63.PubMedCrossRef Fowler A, Thomson D, Giles K, Maleki S, Mreich E, et al. miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion. Eur J Cancer. 2011;47(6):953–63.PubMedCrossRef
9.
Zurück zum Zitat Wu ZS, Wu Q, Wang CQ, Wang XN, Huang J, et al. miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met. Cancer. 2011 [Epub ahead of print]. Wu ZS, Wu Q, Wang CQ, Wang XN, Huang J, et al. miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met. Cancer. 2011 [Epub ahead of print].
10.
Zurück zum Zitat Li X, Zhang Y, Shi Y, Dong G, Liang J, et al. MicroRNA-107, an oncogene MicroRNA that regulates tumor invasion and metastasis by targeting DICER1 in gastric cancer: MiR-107 promotes gastric cancer invasion and metastasis. J Cell Mol Med. 2011 [Epub ahead of print]. Li X, Zhang Y, Shi Y, Dong G, Liang J, et al. MicroRNA-107, an oncogene MicroRNA that regulates tumor invasion and metastasis by targeting DICER1 in gastric cancer: MiR-107 promotes gastric cancer invasion and metastasis. J Cell Mol Med. 2011 [Epub ahead of print].
11.
Zurück zum Zitat Hurteau GJ, Carlson JA, Spivack SD, Brock GJ. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res. 2007;67(17):7972–6.PubMedCrossRef Hurteau GJ, Carlson JA, Spivack SD, Brock GJ. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res. 2007;67(17):7972–6.PubMedCrossRef
12.
Zurück zum Zitat Christoffersen NR, Silahtaroglu A, Orom UA, Kauppinen S, Lund AH. miR-200b mediates post-transcriptional repression of ZFHX1B. RNA. 2007;13(8):1172–8.PubMedCrossRef Christoffersen NR, Silahtaroglu A, Orom UA, Kauppinen S, Lund AH. miR-200b mediates post-transcriptional repression of ZFHX1B. RNA. 2007;13(8):1172–8.PubMedCrossRef
13.
Zurück zum Zitat Kong W, Yang H, He L, Zhao JJ, Coppola D, et al. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol. 2008;28(22):6773–84.PubMedCrossRef Kong W, Yang H, He L, Zhao JJ, Coppola D, et al. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol. 2008;28(22):6773–84.PubMedCrossRef
14.
Zurück zum Zitat Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell. 2009;137(6):1032–46.PubMedCrossRef Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell. 2009;137(6):1032–46.PubMedCrossRef
15.
Zurück zum Zitat Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007;449(7163):682–8.PubMedCrossRef Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007;449(7163):682–8.PubMedCrossRef
16.
Zurück zum Zitat Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington’s disease. J Neurosci. 2008;28(53):14341–6.PubMedCrossRef Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington’s disease. J Neurosci. 2008;28(53):14341–6.PubMedCrossRef
17.
Zurück zum Zitat Laneve P, Gioia U, Andriotto A, Moretti F, Bozzoni I, et al. A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiation. Nucleic Acids Res. 2010;38(20):6895–905.PubMedCrossRef Laneve P, Gioia U, Andriotto A, Moretti F, Bozzoni I, et al. A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiation. Nucleic Acids Res. 2010;38(20):6895–905.PubMedCrossRef
18.
19.
Zurück zum Zitat Breen E, Steele G Jr, Mercurio AM. Role of the E-cadherin/alpha-catenin complex in modulating cell–cell and cell–matrix adhesive properties of invasive colon carcinoma cells. Ann Surg Oncol. 1995;2(5):378–85.PubMedCrossRef Breen E, Steele G Jr, Mercurio AM. Role of the E-cadherin/alpha-catenin complex in modulating cell–cell and cell–matrix adhesive properties of invasive colon carcinoma cells. Ann Surg Oncol. 1995;2(5):378–85.PubMedCrossRef
20.
Zurück zum Zitat Aberle H, Butz S, Stappert J, Weissig H, Kemler R, et al. Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J Cell Sci. 1994;107(Pt 12):3655–63.PubMed Aberle H, Butz S, Stappert J, Weissig H, Kemler R, et al. Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J Cell Sci. 1994;107(Pt 12):3655–63.PubMed
21.
Zurück zum Zitat Rimm DL, Koslov ER, Kebriaei P, Cianci CD, Morrow JS. Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc Natl Acad Sci USA. 1995;92(19):8813–7.PubMedCrossRef Rimm DL, Koslov ER, Kebriaei P, Cianci CD, Morrow JS. Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc Natl Acad Sci USA. 1995;92(19):8813–7.PubMedCrossRef
22.
Zurück zum Zitat Pappas DJ, Rimm DL. Direct interaction of the C-terminal domain of alpha-catenin and F-actin is necessary for stabilized cell-cell adhesion. Cell Commun Adhes. 2006;13(3):151–70.PubMedCrossRef Pappas DJ, Rimm DL. Direct interaction of the C-terminal domain of alpha-catenin and F-actin is necessary for stabilized cell-cell adhesion. Cell Commun Adhes. 2006;13(3):151–70.PubMedCrossRef
23.
Zurück zum Zitat Gofuku J, Shiozaki H, Tsujinaka T, Inoue M, Tamura S, et al. Expression of E-cadherin and alpha-catenin in patients with colorectal carcinoma. Correlation with cancer invasion and metastasis. Am J Clin Pathol. 1999;111(1):29–37.PubMed Gofuku J, Shiozaki H, Tsujinaka T, Inoue M, Tamura S, et al. Expression of E-cadherin and alpha-catenin in patients with colorectal carcinoma. Correlation with cancer invasion and metastasis. Am J Clin Pathol. 1999;111(1):29–37.PubMed
24.
Zurück zum Zitat Kitagawa T, Matsumoto K, Nagafuchi A, Tsukita S, Suzuki H. Co-expression of E-cadherin and alpha-catenin molecules in colorectal cancer. Surg Today. 1999;29(6):511–8.PubMedCrossRef Kitagawa T, Matsumoto K, Nagafuchi A, Tsukita S, Suzuki H. Co-expression of E-cadherin and alpha-catenin molecules in colorectal cancer. Surg Today. 1999;29(6):511–8.PubMedCrossRef
25.
Zurück zum Zitat Raftopoulos I, Davaris P, Karatzas G, Karayannacos P, Kouraklis G. Level of alpha-catenin expression in colorectal cancer correlates with invasiveness, metastatic potential, and survival. J Surg Oncol. 1998;68(2):92–9.PubMedCrossRef Raftopoulos I, Davaris P, Karatzas G, Karayannacos P, Kouraklis G. Level of alpha-catenin expression in colorectal cancer correlates with invasiveness, metastatic potential, and survival. J Surg Oncol. 1998;68(2):92–9.PubMedCrossRef
26.
Zurück zum Zitat Drees F, Pokutta S, Yamada S, Nelson WJ, Weis WI. Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Cell. 2005;123(5):903–15.PubMedCrossRef Drees F, Pokutta S, Yamada S, Nelson WJ, Weis WI. Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Cell. 2005;123(5):903–15.PubMedCrossRef
Metadaten
Titel
MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility
verfasst von
Liang Zhu
Huarong Chen
Donger Zhou
Dan Li
Rui Bai
Shu Zheng
Weiting Ge
Publikationsdatum
01.06.2012
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 2/2012
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-011-9975-z

Weitere Artikel der Ausgabe 2/2012

Medical Oncology 2/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.